Mounjaro now appears on LillyDirect, Eli Lilly’s direct-to-patient pharmacy, and Lilly has signaled a self-pay pathway for it following a November 2025 federal pricing agreement that called for adding Mounjaro at roughly 50% to 60% off list. But as of mid-2026, the well-known discounted vial prices you’ve probably seen, $299, $399, and $449 a month, belong to Zepbound, not Mounjaro, and a firm, consistently published Mounjaro self-pay figure hasn’t fully settled. The short version: if your goal is weight loss and you’re paying cash, Zepbound through LillyDirect remains the confirmed cheaper tirzepatide route, since it’s the same active ingredient at the same doses from the same maker.<\/p>\n
Here’s where things actually stand, and why the Mounjaro-versus-Zepbound distinction trips people up.<\/p>\n
Mounjaro is listed on the LillyDirect medicines page, and Lilly’s pricing materials point cash-pay and uninsured patients toward a LillyDirect self-pay option for it. That’s a change from most of 2025, when LillyDirect’s discounted direct-pay program ran for Zepbound only and there was no equivalent for Mounjaro at all.<\/p>\n
What hasn’t fully landed is a clear, stable price tag. The November 2025 agreement committed Lilly to offering Mounjaro through LillyDirect at about 50% to 60% below list, but as of this writing the exact self-pay dollar figures aren’t quoted consistently across Lilly’s own channels the way Zepbound’s are. A 50% to 60% cut off Mounjaro’s list price would put it somewhere in the mid-hundreds per month, but until Lilly posts firm numbers, treat any precise figure you see with caution and check LillyDirect directly for current pricing.<\/p>\n
Mounjaro and Zepbound are the same molecule, tirzepatide, from the same manufacturer. The difference is the label. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is approved for chronic weight management and obstructive sleep apnea. That single distinction drives nearly everything about cost and access.<\/p>\n
The discounted self-pay vial program was built for the weight-loss product. So the $299, $399, and $449 prices that circulate online are Zepbound’s, and applying them to Mounjaro is the most common mistake in cash-pay GLP-1 shopping. Here’s the current landscape.<\/p>\n